SLU-PP-332

SLU-PP-332 in Canada is supplied by Horizon Peptides as a lyophilized powder in sealed 5 mg research vials, available singly or in 3-vial and 10-vial packs. The vial format supplies the compound as a bulk powder for laboratories setting their own working concentrations.

Supplied as a powder, this format leaves concentration entirely to the laboratory. That matters more for a tool compound than for most material, because a synthetic agonist is typically screened across a wide concentration range before any single working level is settled on.

The compound itself is a small synthetic molecule targeting the estrogen-related receptor family, developed at Saint Louis University, whose initials open the name. Those receptors have no firmly established natural binding partner, so a designed agonist is the main route to studying them.

A 5 mg vial goes considerably further at the concentrations this class is typically screened at than the microgram quantities the pre-portioned format supplies, which is the practical reason a screening study would choose the powder.

Where a fixed quantity is wanted instead, the same compound is stocked as SLU-PP-332 capsules. Another non-peptide research compound is Cardarine capsules, and related mitochondrial material includes MOTS-c.